Aarey Drugs & Pharmaceuticals Ltd

Aarey Drugs Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Aarey Drugs & Pharmaceuticals Ltd

₹ 47.0 -0.11%
02 Jul - close price
aareydrugs.com BSE: 524412 NSE: AAREYDRUGS
About

Incorporated in 1990, Aarey Drugs & Pharmaceuticals Ltd is a manufacturer of API / Bulk Drugs and offers products for diverse
industrial applications[1]

Key Points

Business Overview:[1]
ADPL does manufacturing of active pharmaceutical ingredients, intermediates, specialty chemicals, and trading of industrial solvents & chemicals. It caters to pharmaceuticals formulation manufacturers and pharmaceutical merchant exports.

Website BSE NSE - BE
  • Market Cap ₹ 119 Cr.
  • Current Price ₹ 47.0
  • High / Low ₹ 68.0 / 30.0
  • Stock P/E 25.5
  • Book Value ₹ 52.3
  • Dividend Yield 0.00 %
  • ROCE 4.44 %
  • ROE 3.78 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Stock is trading at 0.90 times its book value

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Promoter holding has decreased over last quarter: -4.76%
  • The company has delivered a poor sales growth of 2.22% over past five years.
  • Tax rate seems low
  • Company has a low return on equity of 4.40% over last 3 years.
  • Company might be capitalizing the interest cost
  • Earnings include an other income of Rs.6.96 Cr.
  • Company has high debtors of 170 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs

Edit Columns
Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
178.25 97.52 134.65 140.27 120.25 118.84 76.26 62.47 162.88 50.96 57.83 76.48 210.35
175.89 94.59 131.23 137.21 118.38 117.93 71.99 60.94 160.36 49.62 55.99 73.78 211.79
Operating Profit 2.36 2.93 3.42 3.06 1.87 0.91 4.27 1.53 2.52 1.34 1.84 2.70 -1.44
OPM % 1.32% 3.00% 2.54% 2.18% 1.56% 0.77% 5.60% 2.45% 1.55% 2.63% 3.18% 3.53% -0.68%
1.64 0.67 0.81 0.13 1.13 0.85 -0.94 0.48 0.84 0.70 0.84 0.29 5.14
Interest 0.56 0.47 0.61 0.49 0.43 0.55 0.59 0.71 0.20 0.42 0.41 0.47 0.40
Depreciation 0.25 0.40 0.50 0.50 0.59 0.41 0.42 0.55 1.02 0.89 1.27 1.06 1.15
Profit before tax 3.19 2.73 3.12 2.20 1.98 0.80 2.32 0.75 2.14 0.73 1.00 1.46 2.15
Tax % 55.80% 8.06% 8.97% 11.36% 137.88% 0.00% 9.05% -33.33% 83.18% 0.00% -22.00% -30.14% -0.47%
1.41 2.51 2.84 1.95 -0.76 0.80 2.12 1.00 0.36 0.72 1.23 1.91 2.15
EPS in Rs 0.60 1.07 1.21 0.77 -0.30 0.32 0.84 0.39 0.14 0.28 0.48 0.75 0.85
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
172 200 213 246 396 349 354 298 348 493 419 396
170 198 212 245 386 342 347 294 344 481 411 391
Operating Profit 2 1 1 1 10 8 8 3 5 11 8 4
OPM % 1% 1% 1% 0% 2% 2% 2% 1% 1% 2% 2% 1%
0 2 3 3 3 3 4 7 7 3 3 7
Interest 1 1 1 2 4 2 2 2 2 2 3 2
Depreciation 1 1 1 1 1 1 1 1 1 2 2 4
Profit before tax 1 1 1 2 8 8 9 7 8 10 6 5
Tax % 27% 22% 23% 29% 31% 25% 27% 20% 21% 35% 37% 12%
1 1 1 1 5 6 7 6 7 7 4 5
EPS in Rs 0.39 0.62 0.65 0.77 3.02 2.64 2.80 2.48 2.78 2.58 1.49 1.84
Dividend Payout % 0% 0% 0% 0% 0% 0% 4% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: 7%
5 Years: 2%
3 Years: 4%
TTM: -6%
Compounded Profit Growth
10 Years: 16%
5 Years: -6%
3 Years: -10%
TTM: 24%
Stock Price CAGR
10 Years: 11%
5 Years: 19%
3 Years: 8%
1 Year: 39%
Return on Equity
10 Years: 6%
5 Years: 5%
3 Years: 4%
Last Year: 4%

Balance Sheet

Figures in Rs. Crores

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity Capital 17 17 17 17 18 23 23 23 23 25 25 28
Reserves 17 18 19 20 30 55 61 67 73 86 90 105
5 6 11 15 10 3 16 18 18 14 38 31
69 67 69 74 84 89 45 86 118 120 139 141
Total Liabilities 107 107 115 125 142 170 146 194 233 245 291 305
4 4 6 8 12 12 12 12 14 14 14 15
CWIP 0 0 0 0 0 0 0 0 0 0 0 0
Investments 3 0 0 0 0 0 0 0 0 0 0 1
99 102 109 117 130 157 133 181 218 230 277 289
Total Assets 107 107 115 125 142 170 146 194 233 245 291 305

Cash Flows

Figures in Rs. Crores

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
3 -0 3 6 1 -20 1 3 5 0 -1 -3
-3 2 -2 -3 -5 -1 -1 -1 -3 -3 0 -2
-1 -1 -2 -2 4 23 -2 -2 -2 2 1 5
Net Cash Flow -1 0 -1 1 -1 2 -3 0 0 -0 1 1

Ratios

Figures in Rs. Crores

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 141 119 114 108 75 100 109 118 170 101 165 170
Inventory Days 16 10 7 3 5 16 23 21 20 11 26 33
Days Payable 146 119 117 108 71 84 40 98 120 86 117 123
Cash Conversion Cycle 11 9 5 3 9 32 92 42 69 26 75 80
Working Capital Days 64 62 68 61 44 72 94 121 110 76 118 130
ROCE % 4% 6% 7% 7% 22% 14% 12% 9% 10% 10% 6%

Shareholding Pattern

Numbers in percentages

Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024
49.38% 49.38% 48.05% 48.06% 50.03% 50.04% 50.04% 50.05% 50.04% 50.04% 50.04% 45.28%
3.42% 4.47% 4.26% 4.23% 3.92% 3.98% 3.92% 3.92% 3.92% 3.94% 3.83% 3.40%
47.19% 46.14% 47.69% 47.70% 46.04% 45.97% 46.04% 46.04% 46.03% 46.01% 46.12% 51.31%
No. of Shareholders 12,82813,15813,65817,56517,77717,64917,78517,69917,53816,08615,26916,843

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Right Issue

Credit ratings